Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-18-001880
Filing Date
2018-02-14
Accepted
2018-02-14 17:14:57
Documents
48
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q1217_citiuspharma.htm 10-Q 283196
2 RELEASE AGREEMENT, DATED NOVEMBER 7, 2017, BETWEEN CITIUS PHARMACEUTICALS, INC., f10q1217ex10-1_citius.htm EX-10.1 22682
3 CITIUS PHARMACEUTICALS, INC. 2018 OMNIBUS STOCK INCENTIVE PLAN f10q1217ex10-2_citius.htm EX-10.2 185843
4 CERTIFICATION f10q1217ex31-1_citius.htm EX-31.1 16169
5 CERTIFICATION f10q1217ex31-2_citius.htm EX-31.2 15978
6 CERTIFICATION f10q1217ex32-1_citius.htm EX-32.1 10539
  Complete submission text file 0001213900-18-001880.txt   2602097

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE ctxr-20171231.xml EX-101.INS 351104
8 XBRL SCHEMA FILE ctxr-20171231.xsd EX-101.SCH 35917
9 XBRL CALCULATION FILE ctxr-20171231_cal.xml EX-101.CAL 29719
10 XBRL DEFINITION FILE ctxr-20171231_def.xml EX-101.DEF 106760
11 XBRL LABEL FILE ctxr-20171231_lab.xml EX-101.LAB 284179
12 XBRL PRESENTATION FILE ctxr-20171231_pre.xml EX-101.PRE 198906
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-38174 | Film No.: 18613634
SIC: 2834 Pharmaceutical Preparations